Discover investment opportunities in Top 30 Stocks Under $18 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 30 Stocks Under $18 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 30 Stocks Under $18 using our Smart AI Filter.
6 stocks found for "Top 30 Stocks Under $18"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.26 Risk measure | ±56.0% Price volatility | -61.7 Valuation | 0.00% Annual yield | |||
1.12 Risk measure | ±67.2% Price volatility | 8.2 Valuation | 0.00% Annual yield | |||
0.79 Risk measure | ±46.9% Price volatility | -62.2 Valuation | 0.00% Annual yield | |||
0.42 Risk measure | ±21.7% Price volatility | 6.9 Valuation | 12.99% Annual yield | |||
0.09 Risk measure | ±52.5% Price volatility | -52.4 Valuation | 0.00% Annual yield | |||
0.76 Risk measure | ±96.1% Price volatility | -12.0 Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What sectors are represented in these top stocks under $18?
A: The stocks under $18 on this screener page span various sectors, including mining (e.g., WRN, CDE), healthcare (e.g., TRVI, MAZE), energy (e.g., HURA, NXE), and financials (e.g., FBRT). This diversity offers investors a range of industry exposures and potential opportunities for diversification.
Q: Which of these stocks have potential for growth investors?
A: Stocks like SKYH and NXE may appeal to growth investors due to their involvement in emerging sectors such as next-generation energy solutions and advanced materials. However, growth potential should be evaluated against financial performance and market conditions.
Q: Are there any stocks particularly noted for ESG factors?
A: Some investors might consider NXE, involved in uranium mining, for potential ESG interests within the context of nuclear energy's role in reducing carbon emissions. However, ESG evaluations should always extend beyond industry to assess company-specific practices.
Q: How might these stocks perform in a rising interest rate environment?
A: Mining stocks like CDE and WRN could experience higher volatility during rising interest rates due to fluctuating commodity prices impacting operational costs. Conversely, financial stocks such as FBRT might benefit from improved interest income.
Q: Which stocks might appeal to dividend-seeking investors?
A: FBRT in the financial sector may offer dividends, but investors should review each stock's dividend history and payout ratios for confirmation. Energy and mining stocks typically reinvest profits into operations, offering fewer dividends.
Q: What are the risks of investing in healthcare stocks like TRVI and MAZE?
A: Healthcare stocks, particularly in drug development, often face regulatory hurdles and high R&D costs. The success of their product pipelines can significantly influence stock performance and investor sentiment.
After reaching an important support level, Coeur Mining (CDE) could be a good stock pick from a technical perspective. CDE surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend.
Read moreThe mean of analysts' price targets for Trevi Therapeutics (TRVI) points to a 231.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Read more